SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-20-000014
Filing Date
2020-10-01
Accepted
2020-10-01 09:00:16
Documents
3
Period of Report
2020-10-01
Effectiveness Date
2020-10-01

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 407557
2 proxycard_01.jpg GRAPHIC 167554
3 proxycard_02.jpg GRAPHIC 127679
  Complete submission text file 0001641172-20-000014.txt   815305
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38022 | Film No.: 201214568
SIC: 2834 Pharmaceutical Preparations